J Clin Rheumatol. 2025 Aug 15. doi: 10.1097/RHU.0000000000002270. Online ahead of print. ABSTRACT BACKGROUND: To compare the clinical features and […]
Kidney Int Rep. 2025 Jun 16;10(8):2883-2884. doi: 10.1016/j.ekir.2025.05.053. eCollection 2025 Aug. NO ABSTRACT PMID:40814618 | PMC:PMC12347826 | DOI:10.1016/j.ekir.2025.05.053
Kidney Int Rep. 2025 May 19;10(8):2778-2788. doi: 10.1016/j.ekir.2025.05.011. eCollection 2025 Aug. ABSTRACT INTRODUCTION: Shared decision-making (SDM) is a key process
JTCVS Tech. 2025 Apr 24;32:119-135. doi: 10.1016/j.xjtc.2025.04.014. eCollection 2025 Aug. ABSTRACT OBJECTIVE: Left ventricular pressure overload models using adult mice
Arthritis Rheumatol. 2025 Aug 15. doi: 10.1002/art.43359. Online ahead of print. ABSTRACT OBJECTIVE: Fecal microbiota transplantation (FMT) holds promises as
Arthritis Rheumatol. 2025 Aug 15. doi: 10.1002/art.43360. Online ahead of print. NO ABSTRACT PMID:40814771 | DOI:10.1002/art.43360
BJPsych Open. 2025 Aug 15;11(5):e182. doi: 10.1192/bjo.2025.10806. ABSTRACT BACKGROUND: Catatonia, a neuropsychiatric syndrome, can be associated with inflammatory conditions of
mBio. 2025 Aug 15:e0101025. doi: 10.1128/mbio.01010-25. Online ahead of print. ABSTRACT Respiratory syncytial virus (RSV) is a globally prevalent pathogen,
Rheumatol Ther. 2025 Aug 15. doi: 10.1007/s40744-025-00789-z. Online ahead of print. ABSTRACT INTRODUCTION: Psoriatic arthritis (PsA) is a complex disease
Calcif Tissue Int. 2025 Aug 15;116(1):109. doi: 10.1007/s00223-025-01421-6. ABSTRACT Physical activity (PA) and sedentary behavior (SB) are two key lifestyle
Clin Rheumatol. 2025 Aug 15. doi: 10.1007/s10067-025-07632-4. Online ahead of print. NO ABSTRACT PMID:40815434 | DOI:10.1007/s10067-025-07632-4
J Cardiovasc Pharmacol. 2025 Aug 15. doi: 10.1097/FJC.0000000000001751. Online ahead of print. ABSTRACT The global burden of mortality is largely
Innovation (Camb). 2025 Jul 5;6(8):101015. doi: 10.1016/j.xinn.2025.101015. eCollection 2025 Aug 4. ABSTRACT This phase 3 trial evaluated the efficacy and
J Family Med Prim Care. 2025 Jul;14(7):2672-2679. doi: 10.4103/jfmpc.jfmpc_1458_24. Epub 2025 Jul 21. ABSTRACT INTRODUCTION: Immune-mediated diseases can affect any
Int J Clin Exp Pathol. 2025 Jul 15;18(7):364-374. doi: 10.62347/VFGO9374. eCollection 2025. ABSTRACT OBJECTIVE: Lupus nephritis (LN) is among the
Kidney Int Rep. 2025 May 19;10(8):2864-2868. doi: 10.1016/j.ekir.2025.05.015. eCollection 2025 Aug. NO ABSTRACT PMID:40814606 | PMC:PMC12347802 | DOI:10.1016/j.ekir.2025.05.015
Cell Syst. 2025 Aug 7:101368. doi: 10.1016/j.cels.2025.101368. Online ahead of print. ABSTRACT Although antibody sequences are highly diverse, they are
Autoimmun Rev. 2025 Aug 12:103910. doi: 10.1016/j.autrev.2025.103910. Online ahead of print. ABSTRACT The mechanistic target of rapamycin (mTOR) is a
J Vasc Interv Radiol. 2025 Aug 12:S1051-0443(25)00529-9. doi: 10.1016/j.jvir.2025.08.009. Online ahead of print. ABSTRACT PURPOSE: To evaluate the safety and
Clin Immunol. 2025 Aug 12:110578. doi: 10.1016/j.clim.2025.110578. Online ahead of print. ABSTRACT Genetic factors have been demonstrated to play essential
Indian Heart J. 2025 Aug 12:S0019-4832(25)00164-6. doi: 10.1016/j.ihj.2025.08.001. Online ahead of print. ABSTRACT BACKGROUND: Cardiovascular disease (CVD) risk significantly increases
J Lipid Res. 2025 Aug 12:100876. doi: 10.1016/j.jlr.2025.100876. Online ahead of print. ABSTRACT Hypoxia, resulting from environmental factors or diseases
Rev Colomb Psiquiatr (Engl Ed). 2025 Jan-Mar;54(1):191-194. doi: 10.1016/j.rcpeng.2025.07.003. ABSTRACT INTRODUCTION: Systemic lupus erythematosus (SLE) is an autoimmune disease with
Vitam Horm. 2025;129:125-141. doi: 10.1016/bs.vh.2024.09.001. Epub 2024 Oct 15. ABSTRACT Primary aldosteronism (PA) is composed of different aldosterone-producing lesions including
Lupus Sci Med. 2025 Aug 14;12(2):e001521. doi: 10.1136/lupus-2025-001521. ABSTRACT OBJECTIVE: Using data from participants with paediatric SLE (pSLE) in the
RMD Open. 2025 Aug 14;11(3):e005557. doi: 10.1136/rmdopen-2025-005557. ABSTRACT BACKGROUND: Iscalimab (CFZ533) is a novel, anti-CD40 monoclonal antibody. This study evaluated
RMD Open. 2025 Aug 14;11(3):e005785. doi: 10.1136/rmdopen-2025-005785. ABSTRACT OBJECTIVE: To investigate the prevalence of difficult-to-treat psoriatic arthritis (D2T-PsA) and classify
